home / stock / vxrt / vxrt news


VXRT News and Press, Vaxart Inc. From 10/08/20

Stock Information

Company Name: Vaxart Inc.
Stock Symbol: VXRT
Market: NASDAQ
Website: vaxart.com

Menu

VXRT VXRT Quote VXRT Short VXRT News VXRT Articles VXRT Message Board
Get VXRT Alerts

News, Short Squeeze, Breakout and More Instantly...

VXRT - 2 Healthcare Stocks That Could Soar in 2020

The end of the year is fast approaching. And for investors, several things are worth keeping an eye on between now and December. The presidential race is one example. The results of the November elections in the U.S. could affect the market -- positively or otherwise. Another race to pay at...

VXRT - Vaxart and Kindred Bio expand manufacturing agreement for COVID-19 vaccine candidates

Vaxart (VXRT) and Centaur Biopharmaceutical Services, a subsidiary of Kindred Biosciences (KIN) have expanded their agreement under which Centaur will manufacture Vaxart's oral vaccine for COVID-19 and other vaccine candidates. Centaur is a full-service contract development and manufacturing ...

VXRT - Centaur Biopharmaceutical Services Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates

Centaur Biopharmaceutical Services Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates PR Newswire SAN FRANCISCO, Oct. 7, 2020 SAN FRANCISCO , Oct. 7, 2020 /PRNewswire/ -- Centaur Biopharmaceutical Services Inc...

VXRT - Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates

Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates PR Newswire SAN FRANCISCO, Oct. 7, 2020 SAN FRANCISCO , Oct. 7, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmac...

VXRT - HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates TCMD, VXRT Investors, Encourages Investors with Losses to Contact Firm, Reminds of Critical Upcoming Deadlines

SAN FRANCISCO, CA / ACCESSWIRE / October 6, 2020 / Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact the firm. Further details about the cases, including upcoming application deadlines, can be foun...

VXRT - VAXART INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vaxart, Inc. - VXRT

VAXART INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vaxart, Inc. - VXRT VAXART INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officer...

VXRT - TWLO, IVZ among premarket gainers

Nano-X Imaging (NNOX +25% as company plans to demonstrate its Nanox-ARC system at RSNA 2020.DPW Holdings (DPW +25% after its business launches hybrid EV charger.IDT Corporation (IDT) +18% on Q4 results.Chembio Diagnostics (CEMI +15% on FDA approval for DPP H...

VXRT - Non-GAAP Mike: How To Derive Valuable Signals From Proxy Filings

Mike talks about his time at Relational Investors as part of a (mostly) friendly activist operation, his transition to tech and his substack. Mike is a corporate governance ninja who knows exactly how to read the subtle signs included in proxy and other obscure filings. He also ta...

VXRT - VAXART INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vaxart, Inc. - VXRT

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Vaxart, Inc. (NasdaqGS: VXRT). In early 2020, the Company, which focuses on vaccina...

VXRT - Why Vaxart Stock Is Retreating Today

Shares of the clinical-stage biotech Vaxart (NASDAQ: VXRT) slid by as much as 11.3% in early-morning action Wednesday. The developmental vaccine company's shares appear to be reacting negatively to the news that Johnson & Johnson (NYSE: JNJ) has advanced its single-shot ...

Previous 10 Next 10